Literature DB >> 7676697

Extended gastrectomy: who benefits?

F Köckerling1, T Reck, F P Gall.   

Abstract

In the area of radical surgical treatment of gastric carcinoma, extended or multiorgan resection is--as is systematically extended lymph node dissection--becoming increasingly important. One indication for extended gastrectomy is intramural or transmural infiltration of neighboring organs or the gross presence of metastatic involvement of the lymph nodes associated with the celiac trunk, splenic artery, or splenic hilum. Because the mortality rate associated with extended gastrectomy is hardly any higher than that for nonextended gastrectomy, the indication for the former may be generously applied. The prognostically most unfavorable case is histologic evidence of transmural infiltration of neighboring organs (pT4). Multiorgan resection with improved systematic extension of lymph node dissection is of greatest benefit to patients with inflammatory adhesion of the stomach to neighboring organs or pN2 lymph node metastases. Intramural infiltration of the esophagus can be treated by including the thoracic part of the esophagus in the gastric resection done via an abdominothoracic approach, ensuring an appropriate margin of clearance, with no significant worsening of the prognosis.

Entities:  

Mesh:

Year:  1995        PMID: 7676697     DOI: 10.1007/bf00294716

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  15 in total

1.  Wert der systematischen erweiterten Lymphknotendissektion--Ergebnisse in Japan. [Value of systematic extended lymph node dissection--results in Japan].

Authors:  K Maruyama; M Sasako; T Kinoshita
Journal:  Langenbecks Arch Chir Suppl Kongressbd       Date:  1992

2.  Lymph node metastases of gastric cancer. General pattern in 1931 patients.

Authors:  K Maruyama; P Gunvén; K Okabayashi; M Sasako; T Kinoshita
Journal:  Ann Surg       Date:  1989-11       Impact factor: 12.969

3.  Progress in gastric cancer surgery in Japan and its limits of radicality.

Authors:  K Maruyama; K Okabayashi; T Kinoshita
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

4.  The role of lymph node surgery in gastric cancer.

Authors:  Y Mishima; R Hirayama
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

5.  [Expanded lymph node dissection in stomach and colorectal cancer--uses and risks].

Authors:  F P Gall; P Hermanek
Journal:  Chirurg       Date:  1988-04       Impact factor: 0.955

6.  Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group.

Authors:  J R Siewert; K Böttcher; J D Roder; R Busch; P Hermanek; H J Meyer
Journal:  Br J Surg       Date:  1993-08       Impact factor: 6.939

7.  Lymph node staging in 872 patients with carcinoma of the stomach and the presumed benefit of lymphadenectomy. German Stomach Cancer TNM Study Group.

Authors:  E Keller; H Stützer; K Heitmann; P Bauer; B Gebbensleben; H Rohde
Journal:  J Am Coll Surg       Date:  1994-01       Impact factor: 6.113

8.  Early and late results of extended surgery for cancer of the stomach.

Authors:  F Bozzetti; E Regalia; G Bonfanti; R Doci; D Ballarini; L Gennari
Journal:  Br J Surg       Date:  1990-01       Impact factor: 6.939

9.  [Left upper abdominal quadrant evisceration].

Authors:  Y Hiki; M Nishi
Journal:  Langenbecks Arch Chir Suppl Kongressbd       Date:  1992

10.  [Systematic extended lymph node dissection in curative therapy of stomach cancer].

Authors:  F P Gall; P Hermanek
Journal:  Chirurg       Date:  1993-12       Impact factor: 0.955

View more
  2 in total

1.  Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22.

Authors:  Daisuke Kobayashi; Yasuhiro Kodera; Michitaka Fujiwara; Masahiko Koike; Goro Nakayama; Akimasa Nakao
Journal:  World J Surg       Date:  2011-02       Impact factor: 3.352

2.  Postoperative Quality of Life after Total Gastrectomy Compared with Partial Gastrectomy: Longitudinal Evaluation by European Organization for Research and Treatment of Cancer-OG25 and STO22.

Authors:  Jeong-Hwan Lee; Hyuk-Joon Lee; Yun Suk Choi; Tae Han Kim; Yeon-Ju Huh; Yun-Suhk Suh; Seong-Ho Kong; Han-Kwang Yang
Journal:  J Gastric Cancer       Date:  2016-12-20       Impact factor: 3.720

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.